Earnings Call · Q4 FY2022·2023-03-23

Q4 22EPS +33.33%·Rev n/aQ3 22EPS +9.38%·Rev n/aQ2 22EPS +21.88%·Rev n/aQ1 22EPS +41.38%·Rev n/a⚠ consensus missing

COGNITION THERAPEUTICS INC CGTX

Daniel Kontoh-Boateng — Unknown - likely Investor Relations or Communications

Lisa Ricciardi — President and Chief Executive Officer

Andrew Einhorn — Interim Chief Financial Officer

−1.6%1d on move date−1.9% vs SPY3d+12.4%5d+7.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CGTX calls or request research access.

More CGTX calls Browse calls Request research access